サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1762899

臨床試験支援サービスの世界市場 2025-2029

Global Clinical Trial Support Services Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 215 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
臨床試験支援サービスの世界市場 2025-2029
出版日: 2025年06月28日
発行: TechNavio
ページ情報: 英文 215 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験支援サービス市場は2024-2029年に89億1,610万米ドル、予測期間中のCAGRは7.4％で成長すると予測されます。

当レポートでは、臨床試験支援サービス市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。バイオ医薬品産業の成長、臨床研究に対する政府の取り組み、地域市場における臨床試験の規制などが市場を牽引しています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 6.8%
CAGR 7.4%
増分額 89億1,610万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の臨床試験支援サービス市場の成長を促進する主な理由の一つとして、クロスに対する需要の高まりを挙げています。また、製薬業界を対象とした研究の増加やe-臨床試験に対する需要の高まりは、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 臨床試験支援サービスの世界市場 2019-2023
  • 用途別セグメント分析 2019-2023
  • 年齢層セグメント分析 2019-2023
  • 治療領域セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響：臨床試験支援サービスの世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：用途別

  • 市場セグメント
  • 比較：用途別
  • フェーズ2：市場規模と予測 2024-2029
  • フェーズ3：市場規模と予測 2024-2029
  • フェーズ1：市場規模と予測 2024-2029
  • フェーズ4：市場規模と予測 2024-2029
  • 市場機会：用途別

第9章 市場セグメンテーション：年齢層別

  • 市場セグメント
  • 比較：年齢層別
  • 成人（18歳以上）：市場規模と予測 2024-2029
  • 青少年（10～18歳）：市場規模と予測 2024-2029
  • 子供（10歳未満）：市場規模と予測 2024-2029
  • 市場機会：年齢層別

第10章 市場セグメンテーション：治癒領域別

  • 市場セグメント
  • 比較：治癒領域別
  • 腫瘍学：市場規模と予測 2024-2029
  • 心臓病学：市場規模と予測 2024-2029
  • 神経学：市場規模と予測 2024-2029
  • 感染症：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：治癒領域別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 欧州：市場規模と予測 2024-2029
  • 北米：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • ブラジル：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • インド：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • イタリア：市場規模と予測 2024-2029
  • 韓国：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AH UK Holdco 1 Ltd.
  • Almac Group Ltd.
  • Catalent Inc.
  • Charles River Laboratories International Inc.
  • Eli Lilly and Co.
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Parexel International Corp.
  • Pfizer Inc.
  • Quotient Sciences Ltd.
  • Syneos Health
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co. Ltd.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Clinical Trial Support Services Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Application - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Application
  • Exhibits41: Data Table on Comparison by Application
  • Exhibits42: Chart on Phase 2 - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Phase 2 - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Phase 2 - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Phase 2 - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Phase 3 - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Phase 3 - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Phase 3 - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Phase 3 - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Phase 1 - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Phase 1 - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Phase 1 - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Phase 1 - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Chart on Phase 4 - Market size and forecast 2024-2029 ($ million)
  • Exhibits55: Data Table on Phase 4 - Market size and forecast 2024-2029 ($ million)
  • Exhibits56: Chart on Phase 4 - Year-over-year growth 2024-2029 (%)
  • Exhibits57: Data Table on Phase 4 - Year-over-year growth 2024-2029 (%)
  • Exhibits58: Market opportunity by Application ($ million)
  • Exhibits59: Data Table on Market opportunity by Application ($ million)
  • Exhibits60: Chart on Age Group - Market share 2024-2029 (%)
  • Exhibits61: Data Table on Age Group - Market share 2024-2029 (%)
  • Exhibits62: Chart on Comparison by Age Group
  • Exhibits63: Data Table on Comparison by Age Group
  • Exhibits64: Chart on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Market opportunity by Age Group ($ million)
  • Exhibits77: Data Table on Market opportunity by Age Group ($ million)
  • Exhibits78: Chart on Therapeutic Area - Market share 2024-2029 (%)
  • Exhibits79: Data Table on Therapeutic Area - Market share 2024-2029 (%)
  • Exhibits80: Chart on Comparison by Therapeutic Area
  • Exhibits81: Data Table on Comparison by Therapeutic Area
  • Exhibits82: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Oncology - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Neurology - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits100: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits102: Market opportunity by Therapeutic Area ($ million)
  • Exhibits103: Data Table on Market opportunity by Therapeutic Area ($ million)
  • Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits107: Chart on Geographic comparison
  • Exhibits108: Data Table on Geographic comparison
  • Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Market opportunity By Geographical Landscape ($ million)
  • Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits167: Impact of drivers and challenges in 2024 and 2029
  • Exhibits168: Overview on criticality of inputs and factors of differentiation
  • Exhibits169: Overview on factors of disruption
  • Exhibits170: Impact of key risks on business
  • Exhibits171: Companies covered
  • Exhibits172: Company ranking index
  • Exhibits173: Matrix on companies position and classification
  • Exhibits174: AH UK Holdco 1 Ltd. - Overview
  • Exhibits175: AH UK Holdco 1 Ltd. - Product / Service
  • Exhibits176: AH UK Holdco 1 Ltd. - Key offerings
  • Exhibits177: SWOT
  • Exhibits178: Almac Group Ltd. - Overview
  • Exhibits179: Almac Group Ltd. - Product / Service
  • Exhibits180: Almac Group Ltd. - Key offerings
  • Exhibits181: SWOT
  • Exhibits182: Catalent Inc. - Overview
  • Exhibits183: Catalent Inc. - Business segments
  • Exhibits184: Catalent Inc. - Key offerings
  • Exhibits185: Catalent Inc. - Segment focus
  • Exhibits186: SWOT
  • Exhibits187: Charles River Laboratories International Inc. - Overview
  • Exhibits188: Charles River Laboratories International Inc. - Business segments
  • Exhibits189: Charles River Laboratories International Inc. - Key offerings
  • Exhibits190: Charles River Laboratories International Inc. - Segment focus
  • Exhibits191: SWOT
  • Exhibits192: Eli Lilly and Co. - Overview
  • Exhibits193: Eli Lilly and Co. - Product / Service
  • Exhibits194: Eli Lilly and Co. - Key offerings
  • Exhibits195: SWOT
  • Exhibits196: Eurofins Scientific SE - Overview
  • Exhibits197: Eurofins Scientific SE - Business segments
  • Exhibits198: Eurofins Scientific SE - Key offerings
  • Exhibits199: Eurofins Scientific SE - Segment focus
  • Exhibits200: SWOT
  • Exhibits201: ICON plc - Overview
  • Exhibits202: ICON plc - Product / Service
  • Exhibits203: ICON plc - Key offerings
  • Exhibits204: SWOT
  • Exhibits205: IQVIA Holdings Inc. - Overview
  • Exhibits206: IQVIA Holdings Inc. - Business segments
  • Exhibits207: IQVIA Holdings Inc. - Key offerings
  • Exhibits208: IQVIA Holdings Inc. - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: Laboratory Corp. of America Holdings - Overview
  • Exhibits211: Laboratory Corp. of America Holdings - Business segments
  • Exhibits212: Laboratory Corp. of America Holdings - Key news
  • Exhibits213: Laboratory Corp. of America Holdings - Key offerings
  • Exhibits214: Laboratory Corp. of America Holdings - Segment focus
  • Exhibits215: SWOT
  • Exhibits216: Parexel International Corp. - Overview
  • Exhibits217: Parexel International Corp. - Product / Service
  • Exhibits218: Parexel International Corp. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: Pfizer Inc. - Overview
  • Exhibits221: Pfizer Inc. - Product / Service
  • Exhibits222: Pfizer Inc. - Key news
  • Exhibits223: Pfizer Inc. - Key offerings
  • Exhibits224: SWOT
  • Exhibits225: Quotient Sciences Ltd. - Overview
  • Exhibits226: Quotient Sciences Ltd. - Product / Service
  • Exhibits227: Quotient Sciences Ltd. - Key offerings
  • Exhibits228: SWOT
  • Exhibits229: Syneos Health - Overview
  • Exhibits230: Syneos Health - Product / Service
  • Exhibits231: Syneos Health - Key offerings
  • Exhibits232: SWOT
  • Exhibits233: Thermo Fisher Scientific Inc. - Overview
  • Exhibits234: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits235: Thermo Fisher Scientific Inc. - Key news
  • Exhibits236: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits237: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits238: SWOT
  • Exhibits239: WuXi AppTec Co. Ltd. - Overview
  • Exhibits240: WuXi AppTec Co. Ltd. - Business segments
  • Exhibits241: WuXi AppTec Co. Ltd. - Key offerings
  • Exhibits242: WuXi AppTec Co. Ltd. - Segment focus
  • Exhibits243: SWOT
  • Exhibits244: Inclusions checklist
  • Exhibits245: Exclusions checklist
  • Exhibits246: Currency conversion rates for US$
  • Exhibits247: Research methodology
  • Exhibits248: Information sources
  • Exhibits249: Data validation
  • Exhibits250: Validation techniques employed for market sizing
  • Exhibits251: Data synthesis
  • Exhibits252: 360 degree market analysis
  • Exhibits253: List of abbreviations
目次
Product Code: IRTNTR74267

The clinical trial support services market is forecasted to grow by USD 8,916.1 mn during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the clinical trial support services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.8%
CAGR7.4%
Incremental Value$8,916.1 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's clinical trial support services market is segmented as below:

By Application

    • Phase 2
    • Phase 3
    • Phase 1
    • Phase 4

By Age Group

    • Adults (greater than 18 years)
    • Adolescents (10 to 18 years)
    • Children (less than 10 years)

By Therapeutic Area

    • Oncology
    • Cardiology
    • Neurology
    • Infectious diseases
    • Others

By Geographical Landscape

    • Europe
    • North America
    • Asia
    • Rest of World (ROW)

This study identifies the growing demand for cros as one of the prime reasons driving the clinical trial support services market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.

The report on the clinical trial support services market covers the following areas:

    • Clinical Trial Support Services Market sizing
    • Clinical Trial Support Services Market forecast
    • Clinical Trial Support Services Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial support services market vendors that include AH UK Holdco 1 Ltd., Almac Group Ltd., Brighter Health Network LLC, Catalent Inc., Charles River Laboratories International Inc., Clinipace Inc., Eli Lilly and Co., Eurofins Scientific SE, ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, MARKEN Ltd., Parexel International Corp., Pfizer Inc., Quotient Sciences Ltd., Seveillar Clinical Supplies Services Pvt. Ltd., Syneos Health, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.. Also, the clinical trial support services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Age Group
    • Executive Summary - Chart on Market Segmentation by Therapeutic Area
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Clinical Trial Support Services Market 2019 - 2023
    • Historic Market Size - Data Table on Global Clinical Trial Support Services Market 2019 - 2023 ($ million)
  • 5.2 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.3 Age Group segment analysis 2019 - 2023
    • Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
  • 5.4 Therapeutic Area segment analysis 2019 - 2023
    • Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The impact of AI in the global clinical trial support services market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

  • 8.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 8.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 8.3 Phase 2 - Market size and forecast 2024-2029
    • Chart on Phase 2 - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phase 2 - Market size and forecast 2024-2029 ($ million)
    • Chart on Phase 2 - Year-over-year growth 2024-2029 (%)
    • Data Table on Phase 2 - Year-over-year growth 2024-2029 (%)
  • 8.4 Phase 3 - Market size and forecast 2024-2029
    • Chart on Phase 3 - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phase 3 - Market size and forecast 2024-2029 ($ million)
    • Chart on Phase 3 - Year-over-year growth 2024-2029 (%)
    • Data Table on Phase 3 - Year-over-year growth 2024-2029 (%)
  • 8.5 Phase 1 - Market size and forecast 2024-2029
    • Chart on Phase 1 - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phase 1 - Market size and forecast 2024-2029 ($ million)
    • Chart on Phase 1 - Year-over-year growth 2024-2029 (%)
    • Data Table on Phase 1 - Year-over-year growth 2024-2029 (%)
  • 8.6 Phase 4 - Market size and forecast 2024-2029
    • Chart on Phase 4 - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phase 4 - Market size and forecast 2024-2029 ($ million)
    • Chart on Phase 4 - Year-over-year growth 2024-2029 (%)
    • Data Table on Phase 4 - Year-over-year growth 2024-2029 (%)
  • 8.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Age Group

  • 9.1 Market segments
    • Chart on Age Group - Market share 2024-2029 (%)
    • Data Table on Age Group - Market share 2024-2029 (%)
  • 9.2 Comparison by Age Group
    • Chart on Comparison by Age Group
    • Data Table on Comparison by Age Group
  • 9.3 Adults (greater than 18 years) - Market size and forecast 2024-2029
    • Chart on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
    • Chart on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
    • Data Table on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
  • 9.4 Adolescents (10 to 18 years) - Market size and forecast 2024-2029
    • Chart on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
    • Chart on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
    • Data Table on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
  • 9.5 Children (less than 10 years) - Market size and forecast 2024-2029
    • Chart on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
    • Chart on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
    • Data Table on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Age Group
    • Market opportunity by Age Group ($ million)
    • Data Table on Market opportunity by Age Group ($ million)

10 Market Segmentation by Therapeutic Area

  • 10.1 Market segments
    • Chart on Therapeutic Area - Market share 2024-2029 (%)
    • Data Table on Therapeutic Area - Market share 2024-2029 (%)
  • 10.2 Comparison by Therapeutic Area
    • Chart on Comparison by Therapeutic Area
    • Data Table on Comparison by Therapeutic Area
  • 10.3 Oncology - Market size and forecast 2024-2029
    • Chart on Oncology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
    • Chart on Oncology - Year-over-year growth 2024-2029 (%)
    • Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • 10.4 Cardiology - Market size and forecast 2024-2029
    • Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
    • Chart on Cardiology - Year-over-year growth 2024-2029 (%)
    • Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
  • 10.5 Neurology - Market size and forecast 2024-2029
    • Chart on Neurology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
    • Chart on Neurology - Year-over-year growth 2024-2029 (%)
    • Data Table on Neurology - Year-over-year growth 2024-2029 (%)
  • 10.6 Infectious diseases - Market size and forecast 2024-2029
    • Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
    • Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
  • 10.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 10.8 Market opportunity by Therapeutic Area
    • Market opportunity by Therapeutic Area ($ million)
    • Data Table on Market opportunity by Therapeutic Area ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.4 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.9 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.10 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.11 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.12 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.13 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.14 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.15 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AH UK Holdco 1 Ltd.
    • AH UK Holdco 1 Ltd. - Overview
    • AH UK Holdco 1 Ltd. - Product / Service
    • AH UK Holdco 1 Ltd. - Key offerings
    • SWOT
  • 15.5 Almac Group Ltd.
    • Almac Group Ltd. - Overview
    • Almac Group Ltd. - Product / Service
    • Almac Group Ltd. - Key offerings
    • SWOT
  • 15.6 Catalent Inc.
    • Catalent Inc. - Overview
    • Catalent Inc. - Business segments
    • Catalent Inc. - Key offerings
    • Catalent Inc. - Segment focus
    • SWOT
  • 15.7 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
    • SWOT
  • 15.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.9 Eurofins Scientific SE
    • Eurofins Scientific SE - Overview
    • Eurofins Scientific SE - Business segments
    • Eurofins Scientific SE - Key offerings
    • Eurofins Scientific SE - Segment focus
    • SWOT
  • 15.10 ICON plc
    • ICON plc - Overview
    • ICON plc - Product / Service
    • ICON plc - Key offerings
    • SWOT
  • 15.11 IQVIA Holdings Inc.
    • IQVIA Holdings Inc. - Overview
    • IQVIA Holdings Inc. - Business segments
    • IQVIA Holdings Inc. - Key offerings
    • IQVIA Holdings Inc. - Segment focus
    • SWOT
  • 15.12 Laboratory Corp. of America Holdings
    • Laboratory Corp. of America Holdings - Overview
    • Laboratory Corp. of America Holdings - Business segments
    • Laboratory Corp. of America Holdings - Key news
    • Laboratory Corp. of America Holdings - Key offerings
    • Laboratory Corp. of America Holdings - Segment focus
    • SWOT
  • 15.13 Parexel International Corp.
    • Parexel International Corp. - Overview
    • Parexel International Corp. - Product / Service
    • Parexel International Corp. - Key offerings
    • SWOT
  • 15.14 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.15 Quotient Sciences Ltd.
    • Quotient Sciences Ltd. - Overview
    • Quotient Sciences Ltd. - Product / Service
    • Quotient Sciences Ltd. - Key offerings
    • SWOT
  • 15.16 Syneos Health
    • Syneos Health - Overview
    • Syneos Health - Product / Service
    • Syneos Health - Key offerings
    • SWOT
  • 15.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT
  • 15.18 WuXi AppTec Co. Ltd.
    • WuXi AppTec Co. Ltd. - Overview
    • WuXi AppTec Co. Ltd. - Business segments
    • WuXi AppTec Co. Ltd. - Key offerings
    • WuXi AppTec Co. Ltd. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations